Clinical trials
Recruiting Fatty Liver trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 13 |
| 2024 | 19 |
| 2025 | 20 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 80 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| 89bio, Inc. | 2 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2 |
| Massachusetts General Hospital | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Tanta University | 2 |
| University of Alberta | 2 |
| University of Oxford | 2 |
| AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | 1 |
| Adrian Vella | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 80 |
| Non-alcoholic Fatty Liver Disease | 34 |
| Obesity | 20 |
| Fibrosis | 13 |
| Liver Cirrhosis | 13 |
| Diabetes Mellitus, Type 2 | 9 |
| Liver Diseases | 7 |
| Overweight | 7 |
| Diabetes Mellitus | 5 |
| Inflammation | 5 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.